Total Payments
$23,613
2024 Payments
$338.47
Companies
19
Transactions
84
Medicare Patients
2,640
Medicare Billing
$338,361
Payment Breakdown by Category
Other$17,905 (75.8%)
Food & Beverage$3,227 (13.7%)
Consulting$1,788 (7.6%)
Travel$649.50 (2.8%)
Education$43.98 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,905 | 15 | 75.8% |
| Food and Beverage | $3,227 | 56 | 13.7% |
| Consulting Fee | $1,788 | 2 | 7.6% |
| Travel and Lodging | $649.50 | 8 | 2.8% |
| Education | $43.98 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $14,136 | 30 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $7,168 | 15 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $568.36 | 6 | $0 (2022) |
| Amgen Inc. | $485.79 | 5 | $0 (2019) |
| Medtronic MiniMed, Inc. | $188.67 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.86 | 5 | $0 (2023) |
| Novo Nordisk Inc | $127.84 | 4 | $0 (2019) |
| Abbott Laboratories | $125.01 | 1 | $0 (2019) |
| UCB, Inc. | $120.00 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $93.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $338.47 | 7 | UCB, Inc. ($120.00) |
| 2023 | $16.50 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16.50) |
| 2022 | $148.78 | 3 | AstraZeneca Pharmaceuticals LP ($82.27) |
| 2021 | $18.99 | 1 | Regeneron Healthcare Solutions, Inc. ($18.99) |
| 2020 | $151.73 | 3 | AstraZeneca Pharmaceuticals LP ($116.04) |
| 2019 | $781.72 | 12 | Amgen Inc. ($373.04) |
| 2018 | $5,028 | 15 | Lilly USA, LLC ($4,689) |
| 2017 | $17,129 | 42 | Lilly USA, LLC ($9,434) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $59.35 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $21.83 | General |
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $71.69 | General |
| Category: Endocrinology | ||||||
| 06/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $120.00 | General |
| 05/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: DIABETES | ||||||
| 12/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $47.52 | General |
| 05/31/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $82.27 | General |
| 05/27/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/19/2021 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/26/2020 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Durable Pump | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2020 | Lilly USA, LLC | BAQSIMI (Drug), HUMULIN R 500 | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 12/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $45.83 | General |
| Category: DIABETES | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Diabetes | ||||||
| 12/04/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $116.46 | General |
| 11/21/2019 | Novo Nordisk Inc | Ozempic (Drug), Tresiba | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 11/21/2019 | Novo Nordisk Inc | Ozempic (Drug), Tresiba | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 11/07/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
| 05/15/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $112.19 | General |
| Category: Bone Health | ||||||
| 04/26/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Bone Health | ||||||
| 04/24/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 678 | 1,067 | $383,469 | $99,868 |
| 2022 | 7 | 604 | 921 | $335,404 | $86,741 |
| 2021 | 8 | 627 | 881 | $328,982 | $80,794 |
| 2020 | 12 | 731 | 926 | $260,411 | $70,957 |
Total Patients
2,640
Total Services
3,795
Medicare Billing
$338,361
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 419 | 768 | $290,304 | $73,551 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 73 | $38,544 | $10,119 | 26.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 33 | 36 | $13,572 | $3,442 | 25.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 43 | 44 | $9,250 | $3,325 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,247 | $3,219 | 28.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,385 | $2,261 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 46 | $3,634 | $1,573 | 43.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 28 | 51 | $5,049 | $1,406 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $3,484 | $973.55 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 392 | 662 | $251,560 | $63,900 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 55 | 62 | $33,046 | $9,031 | 27.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 52 | 63 | $23,940 | $6,279 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $12,350 | $2,881 | 23.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $5,713 | $2,037 | 35.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 27 | 56 | $5,656 | $1,606 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $3,139 | $1,007 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 376 | 605 | $238,538 | $58,257 | 24.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 82 | 96 | $37,818 | $8,392 | 22.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 56 | $30,714 | $7,786 | 25.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 37 | 37 | $6,414 | $2,415 | 37.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $7,112 | $1,740 | 24.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 13 | $3,606 | $854.21 | 23.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $2,470 | $735.30 | 29.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 19 | 22 | $2,310 | $615.00 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 334 | 490 | $163,170 | $40,338 | 24.7% |
About Dr. Ronald Ruby, MD
Dr. Ronald Ruby, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Manhattan Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568475044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Ruby, MD has received a total of $23,613 in payments from pharmaceutical and medical device companies, with $338.47 received in 2024. These payments were reported across 84 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,905).
As a Medicare-enrolled provider, Ruby has provided services to 2,640 Medicare beneficiaries, totaling 3,795 services with total Medicare billing of $338,361. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Manhattan Beach, CA
- Active Since 08/14/2006
- Last Updated 10/22/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1568475044
Products in Payments
- FORTEO (Drug) $14,107
- INVOKANA (Drug) $7,168
- EVENITY (Biological) $373.04
- FARXIGA (Drug) $369.63
- Minimed 670G System (Device) $188.67
- FreeStyle Libre Pro (Device) $125.01
- JARDIANCE (Drug) $115.34
- Prolia (Biological) $112.75
- PRALUENT (Drug) $93.05
- Victoza (Drug) $86.46
- Vascepa (Drug) $80.46
- Dexcom G6 Transmitter (Medical Supply) $71.69
- ELIQUIS (Drug) $65.60
- Korlym (Drug) $59.35
- Da Vinci Surgical System (Device) $57.12
- Ozempic (Drug) $41.38
- EVKEEZA (Biological) $37.98
- OneTouch (Device) $18.65
- HUMALOG (Drug) $16.10
- BAQSIMI (Drug) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.